In a related post, New Alzheimer’s Test, Dr. Perlmutter looked at the striking correlation between the amount of beta amyloid in the brain and the degree of cognitive impairment in Alzheimer’s patients.
by Dr. David Perlmutter
Recently an advisory committee to the Food and Drug Administration unanimously recommended the approval of a diagnostic brain scan for Alzheimer’s disease.
The new technology is based upon imaging and quantifying the amount of a specific protein, beta amyloid, in the brains of patients suspected of having the disease. Continue reading »
-
-
-
Books by Dr. Galland
-
-
-
-
Affiliations
-
Popular Posts
-
-
Copyright © 2008-2011 Applied Nutrition Inc.
By using this website you agree to the Terms and Conditions of Use | Privacy Policy | About | Contact | FAQ